Sökning: WFRF:(Skiada Anna) >
Colistin plus merop...
Colistin plus meropenem for carbapenem-resistant Gram-negative infections : in vitro synergism is not associated with better clinical outcomes
-
- Nutman, Amir (författare)
- Tel Aviv Med Ctr & Sch Med, Natl Inst Infect Control & Antibiot Resistance, Tel Aviv, Israel.;Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
-
- Lellouche, Jonathan (författare)
- Tel Aviv Med Ctr & Sch Med, Natl Inst Infect Control & Antibiot Resistance, Tel Aviv, Israel.
-
- Temkin, Elizabeth (författare)
- Tel Aviv Med Ctr & Sch Med, Natl Inst Infect Control & Antibiot Resistance, Tel Aviv, Israel.
-
visa fler...
-
- Daikos, George (författare)
- Laikon Gen Hosp, Dept Med 1, Athens, Greece.;Natl & Kapodistrian Univ Athens, Athens, Greece.
-
- Skiada, Anna (författare)
- Laikon Gen Hosp, Dept Med 1, Athens, Greece.;Natl & Kapodistrian Univ Athens, Athens, Greece.
-
- Durante-Mangoni, Emanuele (författare)
- Univ Campania Luigi Vanvitelli, Dept Precis Med, Naples, Italy.;AORN Colli Monaldi Hosp, Naples, Italy.
-
- Dishon-Benattar, Yael (författare)
- Rambam Hlth Care Campus, Inst Infect Dis, Haifa, Israel.;Univ Haifa, Cheryl Spencer Inst Nursing Res, Haifa, Israel.
-
- Bitterman, Roni (författare)
- Rambam Hlth Care Campus, Inst Infect Dis, Haifa, Israel.
-
- Yahav, Dafna (författare)
- Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.;Beilinson Med Ctr, Rabin Med Ctr, Infect Dis Unit, Petah Tiqwa, Israel.
-
- Daitch, Vered (författare)
- Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.;Beilinson Med Ctr, Rabin Med Ctr, Infect Dis Unit, Petah Tiqwa, Israel.
-
- Bernardo, Mariano (författare)
- Univ Campania Luigi Vanvitelli, Dept Precis Med, Naples, Italy.;AORN Colli Monaldi Hosp, Naples, Italy.
-
- Iossa, Domenico (författare)
- Univ Campania Luigi Vanvitelli, Dept Precis Med, Naples, Italy.;AORN Colli Monaldi Hosp, Naples, Italy.
-
- Zusman, Oren (författare)
- Beilinson Med Ctr, Dept Med E, Rabin Med Ctr, Peta Tikva, Israel.
-
- Friberg, Lena (författare)
- Uppsala universitet,Institutionen för farmaceutisk biovetenskap
-
- Mouton, Johan W. (författare)
- Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.
-
- Theuretzbacher, Ursula (författare)
- Ctr Antiinfect Agents, Vienna, Austria.
-
- Leibovici, Leonard (författare)
- Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.;Beilinson Med Ctr, Dept Med E, Rabin Med Ctr, Peta Tikva, Israel.
-
- Paul, Mical (författare)
- Rambam Hlth Care Campus, Inst Infect Dis, Haifa, Israel.;Techion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.
-
- Carmeli, Yehuda (författare)
- Tel Aviv Med Ctr & Sch Med, Natl Inst Infect Control & Antibiot Resistance, Tel Aviv, Israel.;Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
-
visa färre...
-
Tel Aviv Med Ctr & Sch Med, Natl Inst Infect Control & Antibiot Resistance, Tel Aviv, Israel;Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel. Tel Aviv Med Ctr & Sch Med, Natl Inst Infect Control & Antibiot Resistance, Tel Aviv, Israel. (creator_code:org_t)
- Elsevier BV, 2020
- 2020
- Engelska.
-
Ingår i: Clinical Microbiology and Infection. - : Elsevier BV. - 1198-743X .- 1469-0691. ; 26:9, s. 1185-1191
- Relaterad länk:
-
http://www.clinicalm...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- ObjectivesIn vitro models showing synergism between polymyxins and carbapenems support combination treatment for carbapenem-resistant Gram-negative (CRGN) infections. We tested the association between the presence of in vitro synergism and clinical outcomes in patients treated with colistin plus meropenem.MethodsThis was a secondary analysis of AIDA, a randomized controlled trial comparing colistin with colistin–meropenem for severe CRGN infections. We tested in vitro synergism using a checkerboard assay. Based on the fractional inhibitory concentration (ΣFIC) index for each colistin–meropenem combination, we categorized results as synergistic, antagonistic or additive/indifferent. The primary outcome was clinical failure at 14 days. Secondary outcomes were 14- and 28-day mortality and microbiological failure.ResultsThe sample included 171 patients with infections caused by carbapenem-resistant Acinetobacter baumannii (n = 131), Enterobacteriaceae (n = 37) and Pseudomonas aeuruginosa (n = 3). In vitro testing showed synergism for 73 isolates, antagonism for 20 and additivism/indifference for 78. In patients who received any colistin plus meropenem, clinical failure at 14 days was 59/78 (75.6%) in the additivism/indifference group (reference category), 54/73 (74.0%) in the synergism group (adjusted odds ratio (aOR) 0.76, 95% CI 0.31–1.83), and 11/20 (55%) in the antagonism group (aOR 0.77, 95% CI 0.22–2.73). There was no significant difference between groups for any secondary outcome. Comparing the synergism group to patients treated with colistin monotherapy, synergism was not protective against 14-day clinical failure (aOR 0.52, 95% CI 0.26–1.04) or 14-day mortality (aOR1.09, 95% CI 0.60–1.96).DiscussionIn vitro synergism between colistin and meropenem via checkerboard method did not translate into clinical benefit.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
Nyckelord
- Carbapenem resistance
- Checkerboard assay
- Colistin
- Combination treatment
- Gram-negative infections synergism
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Nutman, Amir
-
Lellouche, Jonat ...
-
Temkin, Elizabet ...
-
Daikos, George
-
Skiada, Anna
-
Durante-Mangoni, ...
-
visa fler...
-
Dishon-Benattar, ...
-
Bitterman, Roni
-
Yahav, Dafna
-
Daitch, Vered
-
Bernardo, Marian ...
-
Iossa, Domenico
-
Zusman, Oren
-
Friberg, Lena
-
Mouton, Johan W.
-
Theuretzbacher, ...
-
Leibovici, Leona ...
-
Paul, Mical
-
Carmeli, Yehuda
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Infektionsmedici ...
- Artiklar i publikationen
-
Clinical Microbi ...
- Av lärosätet
-
Uppsala universitet